DECIDE

Decision-making within cells and differentiation entity therapies

 Coordinatore THE UNIVERSITY OF BIRMINGHAM 

 Organization address address: Edgbaston
city: BIRMINGHAM
postcode: B15 2TT

contact info
Titolo: Ms.
Nome: May
Cognome: Chung
Email: send email
Telefono: 441214000000

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 3˙313˙022 €
 EC contributo 3˙313˙022 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-ITN
 Funding Scheme MC-ITN
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-03-01   -   2017-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    THE UNIVERSITY OF BIRMINGHAM

 Organization address address: Edgbaston
city: BIRMINGHAM
postcode: B15 2TT

contact info
Titolo: Ms.
Nome: May
Cognome: Chung
Email: send email
Telefono: 441214000000

UK (BIRMINGHAM) coordinator 753˙274.50
2    NATIONAL UNIVERSITY OF IRELAND, GALWAY

 Organization address address: University Road -
city: GALWAY

contact info
Titolo: Ms.
Nome: Mari
Cognome: Vahey
Email: send email
Telefono: +353 91 49 59 39

IE (GALWAY) participant 550˙419.30
3    UNIVERSITAET BASEL

 Organization address address: Petersplatz 1
city: BASEL
postcode: 4003

contact info
Titolo: Prof.
Nome: Antonius
Cognome: Rolink
Email: send email
Telefono: +41 2671631

CH (BASEL) participant 496˙573.88
4    INSTYTUT FARMACEUTYCZNY

 Organization address address: "UL. RYDYGIERA 8, LOK. 17"
city: WARSAW
postcode: 01-793

contact info
Titolo: Dr.
Nome: Andrzej
Cognome: Kutner
Email: send email
Telefono: 48224563900
Fax: 48224563838

PL (WARSAW) participant 448˙620.90
5    CELENTYX LIMITED

 Organization address address: VINCENT DRIVE 97
city: BIRMINGHAM
postcode: B15 2SQ

contact info
Titolo: Dr.
Nome: Catherine
Cognome: Brady
Email: send email
Telefono: 4412140000000

UK (BIRMINGHAM) participant 285˙056.62
6    INSTITUTE OF CANCER RESEARCH - ROYAL CANCER HOSPITAL

 Organization address address: Old Brompton Road 123
city: LONDON
postcode: SW7 3RP

contact info
Titolo: Mr.
Nome: Yodry
Cognome: Vasquez
Email: send email
Telefono: +44 20 7 153 5296

UK (LONDON) participant 285˙056.62
7    UNIWERSYTET WROCLAWSKI

 Organization address address: Plac Uniwersytecki 1
city: WROCLAW
postcode: 50137

contact info
Titolo: Dr.
Nome: Ewa
Cognome: Marcinkowska
Email: send email
Telefono: +48 71 375 2929
Fax: +48 71 375 2608

PL (WROCLAW) participant 249˙205.66
8    ORBSEN THERAPEUTICS LIMITED

 Organization address address: ORBSEN BUILDING NATIONAL UNIVERSITY OF IRELAND
city: GALWAY

contact info
Titolo: Dr.
Nome: Stephen
Cognome: Elliman
Email: send email
Telefono: +353 87 6545 486

IE (GALWAY) participant 244˙814.45

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

cells    therapy    therapeutic    scientific    aml    itn    leukaemia    treatments    wp    scientists    esrs    differentiation    agents    training   

 Obiettivo del progetto (Objective)

'Our ITN has both scientific and therapeutic targets. Research in Work Package 1 (WP1) aims to advance understanding of normal blood cell development and why primitive cells fail to differentiate in acute myeloid leukaemia (AML). Research in WP2 will use the information gained from WP1 to develop ways of alleviating the differentiation block in AML and so deliver new agents for use in differentiation therapy. This type of therapy aims, using only mildly toxic treatments, to induce terminal maturation of leukaemia cells and accelerate their death. WP2 responds to the urgent need to devise milder treatments, especially for older and frailer AML patients. Participants have already identified a number of promising new therapeutic agents. Working across these two complementary areas will train our Early Stage Researchers (ESR) to understand the translation of new fundamental science into the development of new therapies. The ITN brings together scientists who have made important advances in the fields of haematopoiesis and differentiation therapy, so will provide an excellent scientific training in these areas. Secondments/visits by ESRs to participants who run centres of expertise in leading edge technologies will provide training in these; and the time spent with private sector participants, and the courses they provide, will ensure that ESRs acquire the transferable skills they will need if they are to work well in, and build bridges between, commercial and publicly funded research organisations. ESRs will also receive management training. This research and training, which will develop our ESRs as versatile scientists, will involve the combined efforts of prestigious research institutes and universities, Poland’s leading governmental pharmaceutical R & D institute, two successful biopharmaceutical companies and a leading management consultancy.'

Altri progetti dello stesso programma (FP7-PEOPLE)

CHOLESTRUCTURE (2013)

REGULATION OF CHOLESTEROL HOMEOSTASIS BY THE ARH-MEDIATED ENDOCYTOSIS OF THE LDL RECEPTOR

Read More  

BFM (2011)

Brahms and the Fabric of Modernist Culture

Read More  

CAPZEO (2012)

Microscopic investigations of CO2 capture and scattering on liquid gas interface

Read More